_edited.png)
‘Potency Theater’ Fallout: What Good Times Signals
Fast Facts
Who / Where: Good Times; reported by High Times Magazine
What changed: High Times reports that Good Times says it is done with “potency theater”
Effective / Key date: 2026-09-25
Status: Reported by High Times; specific program details not stated
DMV impact: Not stated in the source
High Times reported that Good Times is “done with potency theater,” a phrase widely used in cannabis to describe the overemphasis on THC percentage as a proxy for quality, value, or effect. While the report does not lay out operational steps or a policy document, the public stance alone is notable in a market that still rewards high numbers on labels. For consumers in DC, Maryland, and Virginia who shop flower, pre-rolls, concentrates, and edibles, it raises fresh questions about how to judge quality, how testing numbers are used, and what really matters for effects and satisfaction.
Below, we unpack what “potency theater” is, why a brand publicly stepping away from that arms race matters, how this interacts with lab testing practices, pricing, and marijuana delivery regulations, and what DMV buyers and delivery operators should watch next. All reported developments in this piece are attributed to the original High Times item; broader analysis is clearly labeled as Bud Lords opinion.
What did High Times report, exactly?
High Times reported on September 25, 2026, that Good Times is “done with potency theater.” The report did not include an implementation date, regulatory filing, or programmatic details.
That one-line headline is enough to spark an industry conversation because it challenges the long-running norm where shelf placement and price too often chase a THC percentage on the label. Even absent a policy memo, the signal challenges retailers, test labs, and delivery menus to rethink how quality is communicated to shoppers.
What does “potency theater” mean in cannabis?
In one or two sentences: “Potency theater” refers to the fixation on THC percentage as a shorthand for quality, often overshadowing other factors like terpenes, minor cannabinoids, cultivar genetics, and how the product was grown, stored, and consumed.
While numbers matter for dosing and compliance, the over-index on a single metric can distort buying decisions. Experienced patients and adult-use consumers often find that two flowers with similar THC percentages can feel markedly different due to terpene profiles, freshness, and individual biology. For edibles, responsible dosing and onset management matter far more than chasing a maximum milligrams-per-serving figure.
Does this change weed delivery rules in DC, Maryland or Virginia?
No. The High Times report concerns a brand’s stance on “potency theater” and does not change cannabis delivery laws or marijuana transport regulations in any DMV jurisdiction.
That said, delivery services and couriers compete on menus and product descriptions. A shift away from number-chasing and toward fuller product information—like terpene highlights, cultivar lineage, and storage dates—could improve customer satisfaction even without any formal regulatory change.
Why a public stance matters for testing, pricing, and labels
In legal and quasi-legal markets alike, retail buyers and consumers have often been taught to equate higher THC with better value. That creates incentives that ripple through the supply chain. A brand stating it won’t play the high-THC-only game could encourage retailers and delivery marketplaces to broaden how they sort, feature, and explain products: think terpene-forward menus, cultivar family groupings, and clearer freshness notes for flower and pre-rolls. For concentrates, it might mean more emphasis on extraction method and live vs. cured resin differences rather than a single potency number. For edibles, it can reinforce safe dosing and consistent onset as the top quality signals.
Timeline and Next Steps
Only one dated development is available from the reporting. No operational roadmap was disclosed. Here’s the limited timeline now, based strictly on the High Times item:
Date | Event | What it means |
|---|---|---|
2026-09-25 | High Times publishes “Good Times Is Done With Potency Theater” | A public stance is on record; specific program details not stated |
2026-09-25 | Headline identifies Good Times as subject | Signals a brand-level positioning against THC-number fixation |
2026-09-25 | No effective date in the report | Timing for any changes remains unspecified in the source |
What to watch next: whether Good Times and peer brands publish concrete packaging or marketing updates (for example, terpene-forward labels or new menu filters), whether retailers shift shelf placement logic, and whether lab reports are communicated in a more holistic way to shoppers.
How This Compares to Other States
Because the High Times item is a brand-level development rather than a statute or rule change, there’s no state-by-state legal contrast to make on this specific report. In general terms, markets like California, Colorado, Massachusetts, and Maryland all require lab testing and potency disclosure, but none of that dictates that THC be the only or primary quality signal to consumers. The industry conversation about moving beyond a single potency number is national, cutting across adult-use and medical programs.
What This Means for DC, Maryland and Virginia Residents
While no local law changed here, the conversation affects how you shop:
Flower and pre-rolls: Ask for harvest or pack dates and dominant terpenes (e.g., myrcene, limonene, caryophyllene). Freshness and aroma often drive experience more than a 2–3% swing in THC.
Concentrates: Clarify extraction type (live rosin vs. hydrocarbon) and storage. Terpene retention and proper handling can matter more than the top-line potency percent.
Edibles: Focus on consistent dosing, onset, and duration. Start low, go slow, especially with new products or when switching from smoking to edibles.
For DC delivery shoppers, better product descriptions beat bigger numbers. In Maryland’s adult-use program, retailers already list testing data—use it to compare terpene profiles and freshness, not just THC. Virginia’s medical market may provide more detailed COAs; consider asking dispensaries or delivery partners to highlight terpene data and minor cannabinoids on menus.
People Also Ask: Will this affect marijuana delivery regulations?
Short answer: No. The report is about branding and product positioning, not courier licensing, transport manifests, or delivery caps. Delivery operators can, however, respond by improving menu education—featuring cultivar lineage, terpene summaries, storage guidance, and responsible edible dosing tips.
Bud Lords Take
Opinion: Breaking the spell of “potency theater” is healthy for consumers and for brands that actually grow and curate quality. It pressures the market to reward flavor, freshness, and feel—qualities you can’t fake with a round number. For delivery menus, that means less chasing 30%+ badges and more building trust with context: when it was packed, how it was stored, what it tastes like, and how most people say it hits. If Good Times sticks with the stance and others follow, we could see fewer inflated labels and more honest product storytelling.
How should shoppers read labels differently now?
Think of THC% as a dosing reference, not a scoreboard. Then look for:
Terpenes: Dominant two or three, expressed as a percentage or mg/g when available.
Freshness: Harvest, cure, and pack dates for flower and pre-rolls.
Formulation: Live vs. cured resin, solventless vs. hydrocarbon for concentrates; emulsification and serving details for edibles.
COA access: Scanable QR codes to a certificate of analysis help you verify the batch.
Search-Friendly Guide: Is weed delivery legal impacted by this?
No. There is no change to cannabis delivery laws or marijuana transport laws in the DMV based on the High Times report. This is a market-culture signal, not a regulatory change.
Practical tips for delivery menus and compliance teams
Ensure labels and menu copy reflect the COA without exaggeration.
Add terpene summaries and harvest/pack dates to product cards.
Train support teams to explain differences between potency, terpenes, and onset.
For edibles, lead with serving size clarity and safe-use guidance.
Did a law or regulation change in this report?
No. High Times reported a brand stance, not a legislative or regulatory action.
What is the risk of chasing only THC percentage?
It can lead to disappointing experiences, mispriced products, and neglect of other quality drivers like terpenes, freshness, and formulation. Two products with similar THC can feel different.
How can I compare flower beyond potency?
Smell and look for cultivar-specific aromas, check harvest/pack dates, and review dominant terpenes. Storage (cool, dark, sealed) matters too.
Does this affect medical patients differently?
Patients may benefit most from full-profile information. Symptom targets often correlate more with terpene patterns and cannabinoid ratios than with a single THC number.
What should delivery services do now?
Improve product education, align menu copy to COAs, and spotlight freshness and terpene data. No compliance rules change here, but better information builds trust.
Attribution
This reporting references the original item from High Times: “Good Times Is Done With Potency Theater.”
Closing Thought
If potency theater fades, menus get more honest and shoppers get happier. Whether you’re grabbing a DC delivery, browsing Maryland shelves, or consulting Virginia’s medical program, treat potency as one piece of the puzzle—and let flavor, freshness, and formulation have a real say.
Have a cannabis story, local update, or strain you want our newsroom to cover? Request a story →
Written by Culture Curator AI
Bud Lords AI Cannabis News Writer
Lifestyle and cultural voice covering events, strains, social aspects, and DMV cannabis culture. More casual, engaging tone.
Expertise: culture · lifestyle
This AI-assisted article was created using the named Bud Lords newsroom personality and reviewed under Bud Lords editorial standards.
Comments